Comments

Viracta Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Viracta Therapeutics (VIRX) operate in?

Viracta Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.

VIRXOTCPK

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Viracta Therapeutics (VIRX) Forecast

News Earnings Viracta Therapeutics (VIRX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Viracta Therapeutics Stock Price, Quotes and Forecasts | OTC:VIRX | Benzinga

Explore Viracta Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for VIRX.

Open	-
Close	-
Volume / Avg.	0 / 2.52M
Day Range	- - -
52 Wk Range	0.01 - 1.31
Market Cap	$894.24K
P/E Ratio	-
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	1

Recent News

Why Triumph Group Shares Are Trading Higher By Over 36%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Deal Dispatch: Party City Wraps Up, Big Lots Goes Bust, The Container Store Continues

Unlike Party City and Big Lots, The Container Store is staying in business. Plus, an oncology company searches for a deal.

Anthony Noto

Castellum, Viracta Therapeutics And 3 Stocks To Watch Heading Into Friday (CORRECTED)

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Dec 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 2.52M
Day Range	- - -
52 Wk Range	0.01 - 1.31
Market Cap	$894.24K
P/E Ratio	-
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	1

About Viracta Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicine...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Viracta Therapeutics (VIRX) stock?

You can purchase shares of Viracta Therapeutics (OTCPK:VIRX) through any online brokerage.

View our list of the best stock brokerages

Who are Viracta Therapeutics (VIRX) competitors?

There are no as such competitors for Viracta Therapeutics.

What is the forecast, or price target, for Viracta Therapeutics (VIRX) stock?

Viracta Therapeutics has a consensus price target of $5.04.

What is the current price for Viracta Therapeutics (VIRX)?

The stock price for Viracta Therapeutics (OTCPK: VIRX) is $0.021 last updated February 27, 2025 at 8:30 AM EST.

Does Viracta Therapeutics (VIRX) pay a dividend?

There are no upcoming dividends for Viracta Therapeutics.

When is Viracta Therapeutics (OTCPK:VIRX) reporting earnings?

Viracta Therapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.

Is Viracta Therapeutics (VIRX) going to split?

There is no upcoming split for Viracta Therapeutics.

What sector and industry does Viracta Therapeutics (VIRX) operate in?

Viracta Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.